γδ T cell explorations seek terra firma

Affiliations

¹ Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal. bssantos@medicina.ulisboa.pt.
² Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.
³ Department of Biochemistry and Molecular Biology, Committee on Immunology, University of Chicago, Chicago, IL, USA.
⁴ Cancer Immunology and Immunotherapy Centre, Institute for Immunology and Immunotherapy, University of Birmingham, Edgbaston, Birmingham, UK.
⁵ Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK. eberlm@cardiff.ac.uk.
⁶ Systems Immunity Research Institute, Cardiff University, Cardiff, UK. eberlm@cardiff.ac.uk.

Bruno Silva-Santos et al. Nat Immunol. 2023 Oct.

. 2023 Oct;24(10):1606-1609.

doi: 10.1038/s41590-023-01606-x.

¹ Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal. bssantos@medicina.ulisboa.pt.
² Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.
³ Department of Biochemistry and Molecular Biology, Committee on Immunology, University of Chicago, Chicago, IL, USA.
⁴ Cancer Immunology and Immunotherapy Centre, Institute for Immunology and Immunotherapy, University of Birmingham, Edgbaston, Birmingham, UK.
⁵ Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK. eberlm@cardiff.ac.uk.
⁶ Systems Immunity Research Institute, Cardiff University, Cardiff, UK. eberlm@cardiff.ac.uk.

No abstract available

Cited by

Editorial: Optimized gene-engineering and combination therapies to boost γδT cell immunotherapeutic performance.
Barisa M, Abate-Daga D, Fisher J. Barisa M, et al. Front Immunol. 2024 Apr 18;15:1414812. doi: 10.3389/fimmu.2024.1414812. eCollection 2024. Front Immunol. 2024. PMID: 38698854 Free PMC article. No abstract available.

1. McKenzie, D. R. et al. Nat. Immunol. 23, 411–422 (2022). - DOI - PubMed - PMC
1. Hayday, A. C. & Vantourout, P. Annu. Rev. Immunol. 38, 487–510 (2020). - DOI - PubMed
1. Willcox, C. R., Mohammed, F. & Willcox, B. E. Immunol. Rev. 298, 25–46 (2020). - DOI - PubMed
1. Castro, C. D., Boughter, C. T., Broughton, A. E., Ramesh, A. & Adams, E. J. Immunol. Rev. 298, 134–152 (2020). - DOI - PubMed
1. Vermijlen, D., Gatti, D., Kouzeli, A., Rus, T. & Eberl, M. Semin. Cell. Dev. Biol. 84, 75–86 (2018). - DOI - PubMed